Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04679441 · ClinicalTrials.gov registry record · Phase 2
A Novel Computer-Based Functional Skills Assessment and Training Program
A Phase 2 study of Mild Cognitive Impairment and Healthy Aging, sponsored by i-Function.
- Active
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
- 2
- Study locations
NCT04679441: Active Phase 2 study of Mild Cognitive Impairment and Healthy Aging, sponsored by i-Function.
NCT04679441 is a Phase 2 study of Mild Cognitive Impairment and Healthy Aging that is active but no longer recruiting, run by i-Function. The registered enrollment target is 180 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (86% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04679441, a Phase 2 study of Mild Cognitive Impairment and Healthy Aging, is active but no longer recruiting, sponsored by i-Function.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
- 2
- Study locations
Study Summary
People with cognitive impairments such as Mild Cognitive Impairment (MCI), often experience difficulty performing everyday routine activities. Further, normative age-related changes in cognition often lead to deficits on previously learned skills and impede new learning such as learning of new technology systems. This is of great concern, given population aging, the increasing number of older adults with cognitive impairments, and the continual deployment of new technologies in everyday contexts. The objectives of this SBIR Phase II study is to build on a previous Phase I SBIR project and refine and further evaluate a novel integrated computer-based functional skills assessment and training (CFSAT) program that provides training on everyday tasks critical to independent living (e.g., financial and medication management) with non-impaired older adults (NC) and adults with MCI.
Primary Outcome
Change in time to Completion time for each module
Conditions Studied
Interventions
- DEVICE The Computerized Functional Skills Assessment and Training Program
- DEVICE Brain HQ Double Decision
Study Locations (2)
Florida
- Ifunction at University of Miami - Miami
New York
- Weill Cornell Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2023-05-31 |
| Phase | Phase 2 |
What the registry record for NCT04679441 still lists
NCT04679441 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which The Computerized Functional Skills Assessment and Training Program is the first listed.
NCT04679441 reports a single indexed study location in Florida, New York.
Frequently Asked Questions
What is clinical trial NCT04679441 about?
NCT04679441 is a clinical study titled "A Novel Computer-Based Functional Skills Assessment and Training Program". People with cognitive impairments such as Mild Cognitive Impairment (MCI), often experience difficulty performing everyday routine activities. Further, normative age-related changes in cognition often lead to deficits on previously learned skills and impede new learning such as learning of new techn...
What is the current status of trial NCT04679441?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2021-08-01. Estimated completion is 2023-05-31.
What conditions does trial NCT04679441 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Healthy Aging.
What interventions are being tested in trial NCT04679441?
The interventions under investigation include: The Computerized Functional Skills Assessment and Training Program (DEVICE), Brain HQ Double Decision (DEVICE).
Who is sponsoring clinical trial NCT04679441?
This trial is sponsored by i-Function, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04679441 being conducted?
This trial has 2 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04679441's enrollment target sits among peer trials
180 56th of 205 higher than 148 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
RECRUITING · Phase 2
-
The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study
RECRUITING · Phase 2
-
Rapamycin - Effects on Alzheimer's and Cognitive Health
RECRUITING · Phase 2
-
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
RECRUITING · Phase 2
-
Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI